Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice
Naoshi Arai, Kouichi Miura, Kenichi Aizawa, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 27
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
Yumin Wang, Joshua S. Fleishman, Tongda Li, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 11
Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 8
The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial
M Mitrović, Ana Dobrosavljević, O Odanovic, et al.
Romanian Journal of Internal Medicine (2024) Vol. 62, Iss. 2, pp. 184-193
Open Access | Times Cited: 7
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Therapeutic modulation of the liver immune microenvironment
Herbert Tilg, Timon E. Adolph, Frank Tacke
Hepatology (2023)
Closed Access | Times Cited: 15
Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses
Abinash Mahapatro, Fnu Bawna, Vikash Kumar, et al.
Clinical Nutrition ESPEN (2023) Vol. 57, pp. 475-486
Closed Access | Times Cited: 15
Diet, oxidative stress and MAFLD: a mini review
Zhiai Hu, Hui Yue, Na Jiang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Quinoa Polyphenol Extract Alleviates Non-Alcoholic Fatty Liver Disease via Inhibiting Lipid Accumulation, Inflammation and Oxidative Stress
Wenjun Yao, Mingcong Fan, Haifeng Qian, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2276-2276
Open Access | Times Cited: 3
Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat
Hikmet Taner Teker, Taha Ceylani, Seda Keskin, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis
Hiroshi Maeda, Kouichi Miura, Kenichi Aizawa, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 805-805
Open Access | Times Cited: 2
The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated Review
Aleksandra Białczyk, Alicja Rajewska, Roman Junik, et al.
Current Research in Nutrition and Food Science Journal (2024) Vol. 12, Iss. 2, pp. 490-501
Open Access | Times Cited: 2
Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics
Burcu Baba, Taha Ceylani, Rafig Gurbanov, et al.
Archives of Gerontology and Geriatrics (2024) Vol. 125, pp. 105517-105517
Open Access | Times Cited: 1
Current strategies for nonalcoholic fatty liver disease treatment (Review)
Jing Sun, Xiuli Jin, Yiling Li
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 4
Open Access | Times Cited: 1
Non-Targeted Metabolomics Reveal Apomorphine’s Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis
Hideo Ogiso, Kouichi Miura, Ryozo Nagai, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1293-1293
Open Access | Times Cited: 1
Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice
Rachel M. Golonka, Beng San Yeoh, Piu Saha, et al.
Hepatology Communications (2023) Vol. 7, Iss. 6
Open Access | Times Cited: 3
Development of hepatic steatosis in male and female mule ducks after respective force-feeding programs
Elham Atallah, Sabrina Trehiou, Valérie Alquier‐Bacquie, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access
Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
Samradhi Singh, Mona Kriti, Roberto Catanzaro, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 435-454
Open Access
Alterations in Glutathione Redox Homeostasis in Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
Lucia Cesarini, Flavia Grignaffini, Anna Alisi, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1461-1461
Open Access
Page 1

Scroll to top